Journals / Abant Tıp Dergisi / 2025 / Cilt: 14 Sayı: 3

Pediatric Choreiform Movement Disorders: A Retrospective Analysis

Hülya Kayılıoğlu(MUĞLA SITKI KOÇMAN ÜNİVERSİTESİ)0000-0001-7335-1985
Deniz Yüksel(UNIVERSITY OF HEALTH SCIENCES)0000-0001-8990-023X
Ayşe Aksoy(ONDOKUZ MAYIS ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-7533-1638
Mehpare Özkan(İSTİNYE ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-0896-8799
Ülkühan Öztoprak(HACETTEPE ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-7309-3215
Çiğdem Genç Sel(ANKARA ETLİK ŞEHİR HASTANESİ)0000-0002-3644-3124
Vehbi Doğan(ANKARA ETLİK ŞEHİR HASTANESİ)0000-0003-3444-3419
Pages
201–207
Publication Date
2025-12-30
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further research is needed to identify relapse predictors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Chorea is a rare hyperkinetic movement disorder in children, characterized by involuntary, irregular, and rapid movements.
📊
Key Findings & Data:This study aims to retrospectively evaluate the clinical features, neuroimaging findings, treatment responses, and prognostic factors in children with choreiform movement disorders, with a focus on relapse rates and treatment efficacy.
💡
Conclusion & Impact:Further research is needed to identify relapse predictors.
🔬Design:Review & Systematic Survey
📍Scope:2010 Verileri
⚙️Variables:Chorea · Juvenile Huntington Disease · Pediatric Movement Disorders

Abstract

Objective: Chorea is a rare hyperkinetic movement disorder in children, characterized by involuntary, irregular, and rapid movements. Sydenham’s chorea (SC), an autoimmune complication of rheumatic fever, is the most common cause of chorea in pediatric populations. This study aims to retrospectively evaluate the clinical features, neuroimaging findings, treatment responses, and prognostic factors in children with choreiform movement disorders, with a focus on relapse rates and treatment efficacy. Materials and Methods: We conducted a retrospective review of pediatric patients diagnosed with choreiform movement disorders at Dr. Sami Ulus Children's Hospital between 2010 and 2018. Demographic data, clinical presentation, neuroimaging findings, treatments, and relapse outcomes were analyzed. Results: Of the 74 patients, 94.6% had secondary chorea, with 91.9% diagnosed with SC. The mean age at diagnosis was 133.5 ± 33.9 months, with 71.2% female. Brain magnetic resonance imaging findings were normal in 71.4% of the patients who underwent it. Haloperidol was the most commonly used treatment, with 87.3% of SC patients showing a positive response. Relapse occurred in 11.6% of patients, with no significant differences in symptom duration, treatment duration, or age at diagnosis between those with and without relapse (p > 0.05). The median time to relapse was 21 months. Conclusion: SC is the most common cause of chorea in children, and haloperidol is an effective first-line treatment. However, relapses remain a concern, highlighting the need for long-term follow-up. No significant differences were found in clinical parameters between relapsing and non-relapsing patients. Further research is needed to identify relapse predictors.

🔖

Cite This Article

Kayılıoğlu, H., Yüksel, D., Aksoy, A., Özkan, M., Öztoprak, Ü., Sel, Ç. G., Doğan, V. (2025). Pediatric Choreiform Movement Disorders: A Retrospective Analysis. Abant Tıp Dergisi, Cilt: 14 Sayı: 3, 201–207. https://doi.org/10.47493/abantmedj.1810025

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. de Gusmao CM, Waugh JL. Inherited and acquired choreas. Semin Pediatr Neurol. 2018;25:42–53.
  2. Baizabal-Carvallo JF, Cardoso F. Chorea in children: etiology, diagnostic approach and management. J Neural Transm (Vienna). 2020;127(10):1323–1334. PMID:32776155.
  3. Shahri NN, Akbari MR, Farhood B. Sydenham's chorea: A clinical review of a major cause of childhood chorea. Pediatr Neurol. 2019;94:9–16.
  4. Orsini A, Foiadelli T, Magistrali M, Carli N, Bagnasco I, Dassi P, et al. A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors. Eur J Paediatr Neurol. 2022;36:1–6.
  5. Gurkas E, Karalok ZS, Taskin BD, Aydogmus U, Guven A, Degerliyurt A, et al. Predictors of recurrence in Sydenham’s chorea: Clinical observation from a single center. Brain Dev. 2016;38(9):827–834.
  6. Korn-Lubetzki I, Brand A, Steiner I. Recurrence of Sydenham Chorea: Implications for Pathogenesis. JAMA Neurol. 2004;61:1261–1264.
  7. Dale RC, Singh H, Troedson C, Pillai S, Gaikiwari S, Kozlowska K. A prospective study of acute movement disorders in children. Dev Med Child Neurol. 2010;52(8):739–748. PMID:20163436.
  8. Punukollu M, Mushet N, Linney M, Hennessy C, Morton M. Neuropsychiatric manifestations of Sydenham's chorea: A systematic review. Dev Med Child Neurol. 2016;58(1):16–28.
  9. Kılıç A, Ünüvar E, Tatlı B, Gökçe M, Ömeroğlu RE, Oğuz F, Sıdal M. Neurologic and cardiac findings in children with Sydenham chorea. Pediatr Neurol. 2007;36(3):159–164.
  10. Quarrell OW, Nance MA, Nopoulos P, Paulsen JS, Smith JA, Squitieri F. Managing juvenile Huntington’s disease. Neurodegener Dis Manag. 2013;3(3):267–276.
  11. Shahri HMM, Nejad EH, Toosi MB, Malek A, Payandeh A. Clinical findings of Sydenham chorea in pediatric patients: A single-center retrospective study. Ann Child Neurol. 2023;31(3):181–188.
  12. Ekici A, Yakut A, Yimenicioglu S, Carman KB, Saylısoy S. Clinical and neuroimaging findings of Sydenham’s chorea. Iran J Pediatr. 2014;24(3):300.
  13. Zijlmans JC. Vascular chorea in adults and children. Handb Clin Neurol. 2011;100:261–270.
  14. Eyre M, Thomas T, Ferrarin E, Khamis S, Zuberi SM, Sie A, et al.; Sydenham’s Chorea Systematic Literature Review Working Group. Treatments and outcomes among patients with Sydenham chorea: A meta-analysis. JAMA Netw Open. 2024;7(4):e246792. PMID:38625703.
  15. Dean SL, Singer HS. Treatment of Sydenham’s chorea: A review of the current evidence. Tremor Other Hyperkinet Mov (N Y). 2017;7:501.
  16. Genel F, Arslanoglu S, Uran N, Saylan B. Sydenham's chorea: Clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens. Brain Dev. 2002;24(2):73–76. PMID:11891095.
  17. Direk M, Epcacan S, Epcacan Z, Yildirim DD, Okuyaz C. Efficacy of levetiracetam in the treatment of Sydenham chorea. Pediatr Int. 2020;62(11):1264–1268.
  18. Özgün N, Akdeniz O. Effectiveness of valproic acid in the treatment of Sydenham's chorea and a literature review. Clin Pediatr (Phila). 2024;63(6):798–804. PMID:37594080.